4.8 Article

CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3

Journal

CANCER CELL
Volume 19, Issue 4, Pages 541-555

Publisher

CELL PRESS
DOI: 10.1016/j.ccr.2011.02.006

Keywords

-

Funding

  1. Ministry of Science and Technology of China [2010CB912800, 2011CB504203, 2009CB521706, 2008ZX10208, 2010CB912103]
  2. Natural Science Foundation of China [30921140312, 30831160515, 30830110, 30772550, 30671930, 30972785, 30973396, 30973505, 30801376, 90913016, 30900497]
  3. Chinese Academy of Science [KSCX1-YW-R65, KSCX2-YW-H-10, KSCX2-YW-R-195]
  4. Natural Science Foundation of Guangdong Province [8251008901000011]
  5. Anhui Province [08040102005]
  6. Guangdong Higher Education Institutes, Sun Yat-sen University [KLB09001]

Ask authors/readers for more resources

Tumor-associated macrophages (TAMs) can influence cancer progression and metastasis, but the mechanism remains unclear. Here, we show that breast TAMs abundantly produce CCL18, and its expression in blood or cancer stroma is associated with metastasis and reduced patient survival. CCL18 released by breast TAMs promotes the invasiveness of cancer cells by triggering integrin clustering and enhancing their adherence to extracellular matrix. Furthermore, we identify PITPNM3 as a functional receptor for CCL18 that mediates CCL18 effect and activates intracellular calcium signaling. CCL18 promotes the invasion and metastasis of breast cancer xenografts, whereas suppressing PITPNM3 abrogates these effects. These findings indicate that CCL18 derived from TAMs plays a critical role in promoting breast cancer metastasis via its receptor, PITPNM3.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available